Purpose: A review of the significant findings related to the use of the thiazolidinediones (TZDs) in the treatment of patients with type 2 diabetes mellitus and heart failure was conducted. Summary: ...
Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered a key biological reason why obesity increases the risk of type 2 diabetes, and it ...
Am J Health Syst Pharm. 2007;64(9):931-936. These favorable effects on cardiovascular surrogate endpoints highlight the TZDs' potential to affect the progression of diabetes and cardiovascular disease ...